(Q44977104)

7 December 2017

title

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial (English)

1 reference

multicenter clinical trial

7 December 2017

0 references

1 reference

1 reference

1 reference

3

1 reference

7 December 2017

1

Henry R Kranzler

1 reference

7 December 2017

Donald R Wesson

2

1 reference

7 December 2017

DrugAbuse Sciences Naltrexone Depot Study Group

series ordinal

4

1 reference

7 December 2017

publication date

1 July 2004

1 reference

Alcoholism: Clinical and Experimental Research

7 December 2017

published in

1 reference

7 December 2017

volume

28

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1051-1059

1 reference

Dopamine D2 receptor binding, Drd2 expression and the number of dopamine neurons in the BXD recombinant inbred series: genetic relationships to alcohol and other drug associated phenotypes

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Diabetic patients' alcohol use and quality of life: relationships with prescribed treatment compliance among older males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Dual dependence: assessment of dependence upon alcohol and illicit drugs, and the relationship of alcohol dependence among drug misusers to patterns of drinking, illicit drug use and health problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Simultaneous development of six LC-MS-MS methods for the determination of multiple analytes in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Adverse effects of oral naltrexone: analysis of data from two clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Substance misuse, psychiatric disorder and violent and disturbed behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

Project MATCH secondary a priori hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000130804.08397.29

10.1097/01.ALC.0000130804.08397.29

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference